The Food and Drug Administration discusses its approval of the Pfizer-BioNTech COVID-19 vaccine, which will now be marketed as Comirnaty, to prevent the disease in individuals 16 years of age and older. Speakers: Acting FDA Commissioner Janet Woodcock, M.D.; Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.

#Reuters #News #Live #FDA #Pfizer-BioNTech #COVID #COVID19 #Delta #vaccine #variant #coronavirus #pandemic #USA #UnitedStates #US #science #health